These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 33984334)

  • 1. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
    Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
    Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
    Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
    Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.
    Yang G; Jang JH; Kim SW; Han SH; Ma KH; Jang JK; Kang HC; Cho YY; Lee HS; Lee JY
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
    Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS
    Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.
    Yang W; Liu L; Wei Y; Fang C; Liu S; Zhou F; Li Y; Zhao G; Guo Z; Luo Y; Li L
    Lab Invest; 2021 Mar; 101(3):369-380. PubMed ID: 33268842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release.
    Pan J; Ou Z; Cai C; Li P; Gong J; Ruan XZ; He K
    Cell Immunol; 2018 Oct; 332():111-120. PubMed ID: 30103942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obeticholic acid improves hepatic steatosis and inflammation by inhibiting NLRP3 inflammasome activation.
    Yang ZY; Liu F; Liu PH; Guo WJ; Xiong GY; Pan H; Wei L
    Int J Clin Exp Pathol; 2017; 10(8):8119-8129. PubMed ID: 31966664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit.
    Flores-Costa R; Duran-Güell M; Casulleras M; López-Vicario C; Alcaraz-Quiles J; Diaz A; Lozano JJ; Titos E; Hall K; Sarno R; Masferrer JL; Clària J
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28263-28274. PubMed ID: 33106416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway.
    Yang F; Lv XT; Lin XL; Wang RH; Wang SM; Wang GE
    Acta Biochim Biophys Sin (Shanghai); 2023 Dec; 55(12):1961-1971. PubMed ID: 37997375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice.
    Qi J; Yan X; Li L; Qiu K; Huang W; Zhou Z
    Int Immunopharmacol; 2023 Oct; 123():110752. PubMed ID: 37573690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation.
    Wang X; Gao Y; Song J; Tang C; Wang M; Que L; Liu L; Zhu G; Chen Q; Yao Y; Xu Y; Li J; Li Y
    Br J Pharmacol; 2017 Jun; 174(12):1841-1856. PubMed ID: 28306139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.
    Sui YH; Luo WJ; Xu QY; Hua J
    World J Gastroenterol; 2016 Feb; 22(8):2533-44. PubMed ID: 26937141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice.
    Liu SY; Huang CC; Yang YY; Huang SF; Lee TY; Li TH; Hou MC; Lin HC
    PLoS One; 2022; 17(12):e0276717. PubMed ID: 36490253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice.
    Jouihan H; Will S; Guionaud S; Boland ML; Oldham S; Ravn P; Celeste A; Trevaskis JL
    Mol Metab; 2017 Nov; 6(11):1360-1370. PubMed ID: 29107284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptanthrin suppresses multiple inflammasome activation to regulate NASH progression by targeting ASC protein.
    Ren L; Yang H; Wang H; Qin S; Zhan X; Li H; Wei Z; Fang Z; Li Q; Liu T; Shi W; Zhao J; Li Z; Bai Z; Xu G; Zhao J
    Phytomedicine; 2024 Aug; 131():155758. PubMed ID: 38843643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
    Gaul S; Leszczynska A; Alegre F; Kaufmann B; Johnson CD; Adams LA; Wree A; Damm G; Seehofer D; Calvente CJ; Povero D; Kisseleva T; Eguchi A; McGeough MD; Hoffman HM; Pelegrin P; Laufs U; Feldstein AE
    J Hepatol; 2021 Jan; 74(1):156-167. PubMed ID: 32763266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.